ARVEE — Arvee Laboratories (India) Income Statement
0.000.00%
- IN₹1.82bn
- IN₹1.77bn
- IN₹384.87m
Annual income statement for Arvee Laboratories (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 474 | 403 | 613 | 303 | 385 |
Cost of Revenue | |||||
Gross Profit | 179 | 179 | 184 | 131 | 178 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 437 | 370 | 561 | 288 | 360 |
Operating Profit | 36.5 | 33.4 | 52 | 15 | 24.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.4 | 34.5 | 61.7 | 18.3 | 28.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.8 | 25.7 | 41.2 | 10.5 | 21.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 26.8 | 25.7 | 41.2 | 10.5 | 21.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.8 | 25.7 | 41.2 | 10.5 | 21.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.44 | 2.29 | 3.74 | 0.95 | 1.95 |